Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
FGG encodes the fibrinogen γ chain, a critical component of the fibrinogen hexamer involved in clot formation. Heterozygous truncating variants in FGG have been reported in individuals with hypodysfibrinogenemia and thrombotic phenotypes, supporting a causal link to thrombophilia. A 54-year-old man carrying a novel frameshift deletion, c.637del (p.Ser213LeufsTer16), presented with multiple unprovoked venous thromboemboli and deep vein thrombosis following myocardial infarction; functional analyses showed reduced clottable fibrinogen levels and altered γ–γ and α–α chain cross-linking ((PMID:26540127)). Computational molecular dynamics of another γ-chain variant, c.1067A>T (p.Asp356Val), predicted local unfolding in the C-terminal module, potentially disrupting D-D interactions essential for fibrin polymerization ((PMID:27677677)).
A large prospective cohort of 1,717 IVF patients carrying common thrombophilic SNPs, including variants in FGG, showed no significant impact on IVF outcomes, indicating that common polymorphisms do not confer appreciable thrombosis risk in this setting ((PMID:26545911)). Nevertheless, rare FGG loss-of-function alleles appear to predispose to thrombophilia via hypodysfibrinogenemia and altered fibrin network architecture.
Key Take-home: Rare truncating and structurally disruptive FGG variants cause hypodysfibrinogenemia with a prothrombotic phenotype, warranting consideration in genetic thrombophilia work-ups.
Gene–Disease AssociationLimitedSingle unrelated proband with FGG c.637del (p.Ser213LeufsTer16) demonstrating thrombophilia (PMID:26540127); no segregation; supportive in silico data Genetic EvidenceLimitedOne heterozygous frameshift variant (c.637del) in a thrombophilic patient (PMID:26540127) Functional EvidenceLimitedIn silico modeling of p.Asp356Val predicts local unfolding of γ-chain (PMID:27677677); functional clot assays inconclusive |